Videos |View More
Surgery has long been the gold standard for treatment of kidney cancer. However, for small kidney cancer, surgery is not always necessary and may cause complications for some patients.Roswell Park Comprehensive Cancer Center has been at ...
Masterclass on Bladder Cancer 2019
The Masterclass on Bladder Cancer at Roswell Park Comprehensive Cancer Center was a two-day course featuring live surgery with panel discussion, presentations, and didactic lectures. Leaders in Urology and bladder cancer treatment from ...
Day 2 (part 3 of 3) of the Masterclass on Bladder Cancer at the Roswell Park Comprehensive Cancer Center featuring a robot-Assisted Radical Cystectomy with Pelvic Lymph Node Dissection and Intracorporeal Ileal Conduit.
Day 2 (part 1 of 3) of the Masterclass on Bladder Cancer at the Roswell Park Comprehensive Cancer Center featuring a robot-Assisted Radical Cystectomy with Pelvic Lymph Node Dissection and Intracorporeal Ileal Conduit.
Day 2 of the Masterclass on Bladder Cancer features a robot-assisted radical cystectomy with pelvic lymph node dissection and intracorporeal ileal conduit.
Recent Advances in Prostate, Bladder and Renal Cancer
Gurkamal Chatta, MD, Clinical Chief of Genitourinary Medicine, gives a presentation on the epidemiology of prostate cancer and the treatment of metastatic disease.
News |View More
Join Roswell Park's Experts at NCCN
Roswell Park invites you to meet some of our leading experts in oncology and patient care at the National Comprehensive Cancer Network's 2025 Annual Meeting in Orlando, FL, on March 28-30.
Join Roswell Park’s Surgical Experts at SSO
2025 Society of Surgical Oncology Annual Meeting in Tampa, FL, on March 27-29.
Phase 3 clinical trial is underway, it will evaluate the potential of combining an investigational drug, the targeted therapy XL092 (brand name Zanzalintinib), with the FDA-approved immunotherapy nivolumab (brand name Opdivo).
This site is intended for healthcare professionals